Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
2/26/24 GSK (GSK) GSK2140944 for Urinary Tract and Reproductive Tract Infections (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
2/14/24 Biotest (BIO:GR) BT524 for Hemostasis Subscribers Only Subscribers Only Subscribers Only
2/13/24 KalVista Pharmaceuticals (KALV) Sebetralstat for Hereditary Angioedema (HAE) Subscribers Only Subscribers Only Subscribers Only
2/11/24 CSL (CSL) CSL112 for Acute Coronary Syndrome (ACS) Subscribers Only Subscribers Only Subscribers Only
2/7/24 Tonix Pharmaceuticals (TNXP) TNX-1900 for Migraine and Other Headaches Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
02/16/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion
02/16/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion
02/24/24 Subscribers Only Subscribers Only Trial Data - Other
02/24/24 Subscribers Only Subscribers Only Related Drug - Biosimilar 351(k) Approval Decision
02/24/24 Subscribers Only Subscribers Only Trial Data - Updated Results